改善银屑病关节炎患者的心血管健康和代谢合并症。
Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritis.
作者信息
Ogdie Alexis, Eder Lihi
机构信息
Perelman School of Medicine, University of Pennsylvania, White Building, Room 5024, 3400 Spruce St, Philadelphia, PA 19104, USA.
Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada.
出版信息
Int J Clin Rheumtol. 2015 Dec;10(6):451-459. doi: 10.2217/ijr.15.45.
Abstract
Numerous studies have suggested a link between psoriatic arthritis (PsA) and comorbidities, in particular cardiovascular disease and metabolic comorbidities such as diabetes. The co-existence of these comorbidities is likely the result of systemic inflammation. In order to improve the health of patients with PsA and provide optimal care, these comorbidities must be addressed. However, little is known about how to improve metabolic and cardiovascular health in patients with PsA. In this perspective, we describe the research needs in the area of improving cardiovascular disease and metabolic comorbidities among patients with PsA.
摘要
众多研究表明银屑病关节炎（PsA）与合并症之间存在关联，尤其是心血管疾病以及如糖尿病等代谢性合并症。这些合并症的共存很可能是全身炎症的结果。为了改善PsA患者的健康状况并提供最佳护理，必须解决这些合并症。然而，对于如何改善PsA患者的代谢和心血管健康，我们知之甚少。从这个角度出发，我们描述了在改善PsA患者心血管疾病和代谢性合并症领域的研究需求。
相似文献
1
Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritis.改善银屑病关节炎患者的心血管健康和代谢合并症。
Int J Clin Rheumtol. 2015 Dec;10(6):451-459. doi: 10.2217/ijr.15.45.
2
Psoriatic arthritis and the association with cardiometabolic disease: a narrative review.银屑病关节炎及其与心脏代谢疾病的关联：一篇叙述性综述。
Ther Adv Musculoskelet Dis. 2021 Mar 2;13:1759720X21998279. doi: 10.1177/1759720X21998279. eCollection 2021.
3
Comorbidities in Psoriatic Arthritis.银屑病关节炎的合并症
Rheum Dis Clin North Am. 2015 Nov;41(4):677-98. doi: 10.1016/j.rdc.2015.07.008. Epub 2015 Sep 5.
4
Comorbidities Associated with Psoriatic Arthritis Compared with Non-psoriatic Spondyloarthritis: A Cross-sectional Study.银屑病关节炎与非银屑病性脊柱关节炎相关合并症的比较：一项横断面研究。
J Rheumatol. 2016 Feb;43(2):376-82. doi: 10.3899/jrheum.141359. Epub 2015 Dec 15.
5
Recognizing and managing comorbidities in psoriatic arthritis.银屑病关节炎中共病的识别与管理。
Curr Opin Rheumatol. 2015 Mar;27(2):118-26. doi: 10.1097/BOR.0000000000000152.
6
Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.银屑病关节炎的综合治疗：合并症及关节外表现的管理
J Rheumatol. 2014 Nov;41(11):2315-22. doi: 10.3899/jrheum.140882.
7
Comorbidities of psoriatic arthritis -- metabolic syndrome and prevention: a report from the GRAPPA 2010 annual meeting.银屑病关节炎的合并症-代谢综合征和预防：从 GRAPPA2010 年年会报告。
J Rheumatol. 2012 Feb;39(2):437-40. doi: 10.3899/jrheum.111244.
8
Comorbidities in Patients with Psoriatic Arthritis.银屑病关节炎患者的合并症
Rambam Maimonides Med J. 2017 Jan 30;8(1):e0004. doi: 10.5041/RMMJ.10279.
9
Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.银屑病和银屑病关节炎的心脏代谢合并症。
Int J Mol Sci. 2017 Dec 25;19(1):58. doi: 10.3390/ijms19010058.
10
Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions.类风湿关节炎和银屑病关节炎的心脏代谢合并症：经验教训和未来方向。
Nat Rev Rheumatol. 2019 Aug;15(8):461-474. doi: 10.1038/s41584-019-0256-0. Epub 2019 Jul 10.
引用本文的文献
1
Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis.多发性硬化症中心血管自主神经功能障碍的当前认识
Heliyon. 2024 Aug 3;10(15):e35753. doi: 10.1016/j.heliyon.2024.e35753. eCollection 2024 Aug 15.
2
Psoriatic arthritis and the association with cardiometabolic disease: a narrative review.银屑病关节炎及其与心脏代谢疾病的关联：一篇叙述性综述。
Ther Adv Musculoskelet Dis. 2021 Mar 2;13:1759720X21998279. doi: 10.1177/1759720X21998279. eCollection 2021.
3
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis.基线身体质量指数对托法替布治疗银屑病关节炎患者的疗效和安全性的影响。
RMD Open. 2021 Jan;7(1). doi: 10.1136/rmdopen-2020-001486.
4
Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry.纳入PSOLAR注册研究的自我报告患有银屑病关节炎的银屑病患者的人口统计学、基线疾病特征及治疗史。
BMC Rheumatol. 2018 Sep 29;2:29. doi: 10.1186/s41927-018-0034-7. eCollection 2018.
5
Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database.美国接受生物制剂治疗的银屑病关节炎患者的治疗模式：来自行政索赔数据库的描述性分析。
J Manag Care Spec Pharm. 2018 Jul;24(7):623-631. doi: 10.18553/jmcp.2018.24.7.623.
6
Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study.银屑病患者心血管风险因素诊断和治疗中的差距：一项国际多中心研究。
J Rheumatol. 2018 Mar;45(3):378-384. doi: 10.3899/jrheum.170379. Epub 2018 Feb 1.
7
The Changing Face of Clinical Trials in Psoriatic Arthritis.银屑病关节炎临床试验的新面貌
Curr Rheumatol Rep. 2017 Apr;19(4):21. doi: 10.1007/s11926-017-0642-z.
本文引用的文献
1
Statin use and mortality in rheumatoid arthritis: a general population-based cohort study.类风湿关节炎患者使用他汀类药物与死亡率：一项基于人群的队列研究。
Ann Rheum Dis. 2016 Jul;75(7):1315-20. doi: 10.1136/annrheumdis-2015-207714. Epub 2015 Aug 5.
2
Lipid and Metabolic Changes in Rheumatoid Arthritis.类风湿关节炎中的脂质与代谢变化
Curr Rheumatol Rep. 2015 Sep;17(9):57. doi: 10.1007/s11926-015-0534-z.
3
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.类风湿关节炎、银屑病和银屑病关节炎合并症管理的循证推荐：加拿大皮肤病学-风湿病学合并症倡议专家意见
J Rheumatol. 2015 Oct;42(10):1767-80. doi: 10.3899/jrheum.141112. Epub 2015 Jul 15.
4
Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process.类风湿关节炎心血管质量指标的制定：采用新型在线流程的国际专家小组研究结果
J Rheumatol. 2015 Sep;42(9):1548-55. doi: 10.3899/jrheum.141603. Epub 2015 Jul 15.
5
The paradoxical role of IL-17 in atherosclerosis.白细胞介素-17在动脉粥样硬化中的矛盾作用。
Cell Immunol. 2015 Sep;297(1):33-9. doi: 10.1016/j.cellimm.2015.05.007. Epub 2015 May 29.
6
Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.类风湿关节炎心血管风险预测评分的推导和内部验证：北美风湿病研究联合会注册研究。
Arthritis Rheumatol. 2015 May;67(8):1995-2003. doi: 10.1002/art.39195.
7
Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.与非类风湿关节炎患者相比，类风湿关节炎患者的血脂水平与主要不良心血管事件的关系。
Arthritis Rheumatol. 2015 May;67(8):2004-10. doi: 10.1002/art.39165.
8
Recognizing and managing comorbidities in psoriatic arthritis.银屑病关节炎中共病的识别与管理。
Curr Opin Rheumatol. 2015 Mar;27(2):118-26. doi: 10.1097/BOR.0000000000000152.
9
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.肿瘤坏死因子抑制剂、甲氨蝶呤、非甾体抗炎药和皮质类固醇对类风湿关节炎、银屑病和银屑病关节炎患者心血管事件的影响：一项系统评价和荟萃分析。
Ann Rheum Dis. 2015 Mar;74(3):480-9. doi: 10.1136/annrheumdis-2014-206624. Epub 2015 Jan 5.
10
The barrier-belief approach in the counseling of physical activity.体育活动咨询中的障碍信念方法。
Patient Educ Couns. 2015 Feb;98(2):129-36. doi: 10.1016/j.pec.2014.10.003. Epub 2014 Oct 17.
Zotero 插件